Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.

Abe K, Yarovinsky FO, Murakami T, Shakhov AN, Tumanov AV, Ito D, Drutskaya LN, Pfeffer K, Kuprash DV, Komschlies KL, Nedospasov SA.

Blood. 2003 Feb 15;101(4):1477-83.

PMID:
12560241
3.

Hematopoietic switch from lymphoid to granulocytic development in 3LL tumor-bearing mice.

Lee JK, Back TC, Komschlies KL, Ruscetti FW, Young HA, Wiltrout RH.

In Vivo. 2001 Jul-Aug;15(4):255-63.

PMID:
11695215
4.

IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

Wigginton JM, Gruys E, Geiselhart L, Subleski J, Komschlies KL, Park JW, Wiltrout TA, Nagashima K, Back TC, Wiltrout RH.

J Clin Invest. 2001 Jul;108(1):51-62.

5.

Interleukin-7 restores immunity in athymic T-cell-depleted hosts.

Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL.

Blood. 2001 Mar 15;97(6):1525-33.

PMID:
11238086
6.

IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation.

Geiselhart LA, Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL.

J Immunol. 2001 Mar 1;166(5):3019-27.

7.

Gastrointestinal cells of IL-7 receptor null mice exhibit increased sensitivity to irradiation.

Welniak LA, Khaled AR, Anver MR, Komschlies KL, Wiltrout RH, Durum S, Ruscetti FR, Blazar BR, Murphy WJ.

J Immunol. 2001 Mar 1;166(5):2924-8.

PMID:
11207240
8.

Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.

Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, Taylor LS, Eagleson B, Secrest L, Southon EA, Reid SW, Tessarollo L, Bray M, McVicar DW, Komschlies KL, Young HA, Biron CA, Sher A, Vande Woude GF.

Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):751-5.

9.

IFN-gamma-dependent delay of in vivo tumor progression by Fas overexpression on murine renal cancer cells.

Lee JK, Sayers TJ, Brooks AD, Back TC, Young HA, Komschlies KL, Wigginton JM, Wiltrout RH.

J Immunol. 2000 Jan 1;164(1):231-9.

10.

Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.

Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH.

J Immunol. 1998 Oct 15;161(8):3957-65.

11.

Development and characterization of a mouse prostate adenocarcinoma cell line: ductal formation determined by extracellular matrix.

Jorcyk CL, Liu ML, Shibata MA, Maroulakou IG, Komschlies KL, McPhaul MJ, Resau JH, Green JE.

Prostate. 1998 Jan 1;34(1):10-22.

PMID:
9428383
12.

Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies.

Young HA, Klinman DM, Reynolds DA, Grzegorzewski KJ, Nii A, Ward JM, Winkler-Pickett RT, Ortaldo JR, Kenny JJ, Komschlies KL.

Blood. 1997 Jan 15;89(2):583-95.

PMID:
9002962
13.

Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.

Grzegorzewski KJ, Komschlies KL, Franco JL, Ruscetti FW, Keller JR, Wiltrout RH.

Blood. 1996 Dec 1;88(11):4139-48.

PMID:
8943848
14.

Evaluation of the antitumor activity of the interleukin-12/pulse interleukin-2 combination.

Wigginton JM, Komschlies KL, Green JE, Cox GW, Jorcyk CL, Back TC, Franco JL, Brunda MJ, Wiltrout RH.

Ann N Y Acad Sci. 1996 Oct 31;795:434-9. No abstract available.

PMID:
8958976
15.

Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.

Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH.

J Natl Cancer Inst. 1996 Jan 3;88(1):38-43.

PMID:
8847724
16.

Diverse immunological and hematological effects of interleukin 7: implications for clinical application.

Komschlies KL, Grzegorzewski KJ, Wiltrout RH.

J Leukoc Biol. 1995 Dec;58(6):623-33. Review.

PMID:
7499959
17.

Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth.

Ghosh P, Komschlies KL, Cippitelli M, Longo DL, Subleski J, Ye J, Sica A, Young HA, Wiltrout RH, Ochoa AC.

J Natl Cancer Inst. 1995 Oct 4;87(19):1478-83.

PMID:
7674335
18.

Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice.

Franco JL, Ghosh P, Wiltrout RH, Carter CR, Zea AH, Momozaki N, Ochoa AC, Longo DL, Sayers TJ, Komschlies KL.

Cancer Res. 1995 Sep 1;55(17):3840-6.

19.

Recombinant human IL-7 administration in mice affects colony-forming units-spleen and lymphoid precursor cell localization and accelerates engraftment of bone marrow transplants.

Boerman OC, Gregorio TA, Grzegorzewski KJ, Faltynek CR, Kenny JJ, Wiltrout RH, Komschlies KL.

J Leukoc Biol. 1995 Aug;58(2):151-8.

PMID:
7643010
20.

Cellular and molecular studies in the treatment of murine renal cancer.

Wiltrout RH, Gregorio TA, Fenton RG, Longo DL, Ghosh P, Murphy WJ, Komschlies KL.

Semin Oncol. 1995 Feb;22(1):9-16. Review.

PMID:
7855624
21.

Mobilization of long-term reconstituting hematopoietic stem cells in mice by recombinant human interleukin 7.

Grzegorzewski KJ, Komschlies KL, Jacobsen SE, Ruscetti FW, Keller JR, Wiltrout RH.

J Exp Med. 1995 Jan 1;181(1):369-74.

22.
23.

Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.

Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL.

Cancer Res. 1994 Jun 1;54(11):2969-72.

24.

Administration of recombinant human interleukin-7 to mice induces the exportation of myeloid progenitor cells from the bone marrow to peripheral sites.

Grzegorzewski K, Komschlies KL, Mori M, Kaneda K, Usui N, Faltynek CR, Keller JR, Ruscetti FW, Wiltrout RH.

Blood. 1994 Jan 15;83(2):377-85.

PMID:
8286738
25.

Effects of rhIL-7 on leukocyte subsets in mice: implications for antitumor activity.

Komschlies KL, Back TT, Gregorio TA, Gruys ME, Damia G, Wiltrout RH, Faltynek CR.

Immunol Ser. 1994;61:95-104. No abstract available.

PMID:
8011760
26.

Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.

Murphy WJ, Back TC, Conlon KC, Komschlies KL, Ortaldo JR, Sayers TJ, Wiltrout RH, Longo DL.

J Clin Invest. 1993 Oct;92(4):1918-24.

27.

Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.

Damia G, Komschlies KL, Futami H, Back T, Gruys ME, Longo DL, Keller JR, Ruscetti FW, Wiltrout RH.

Cancer Res. 1992 Aug 1;52(15):4082-9.

28.
29.

Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes.

Futami H, Eader LA, Komschlies KL, Bull R, Gruys ME, Ortaldo JR, Young HA, Wiltrout RH.

Cancer Res. 1991 Dec 15;51(24):6596-602.

30.

Expression of human IFN-gamma genomic DNA in transgenic mice.

Young HA, Komschlies KL, Ciccarone V, Beckwith M, Rosenberg M, Jenkins NA, Copeland NG, Durum SK.

J Immunol. 1989 Oct 1;143(7):2389-94.

PMID:
2506285
31.

The methylation state of the T cell antigen receptor beta chain gene in subpopulations of mouse thymocytes.

Sakamoto S, Mathieson BJ, Komschlies KL, Bhat NK, Young HA.

Eur J Immunol. 1989 May;19(5):873-9.

PMID:
2525476
32.

Expression of ets genes in mouse thymocyte subsets and T cells.

Bhat NK, Komschlies KL, Fujiwara S, Fisher RJ, Mathieson BJ, Gregorio TA, Young HA, Kasik JW, Ozato K, Papas TS.

J Immunol. 1989 Jan 15;142(2):672-8.

PMID:
2536061
33.

Characterization of RT6 bearing rat lymphocytes. I. Ontogeny of the RT6+ subset.

Mojcik CF, Greiner DL, Medlock ES, Komschlies KL, Goldschneider I.

Cell Immunol. 1988 Jul;114(2):336-46.

PMID:
3260542

Supplemental Content

Loading ...
Support Center